Share |

venture

How TechBio is speeding up clinical trials and cutting through red tape

April 13, 2023

Hanadi Jabado, managing partner at innovation investment fund Sana Capital, talks about how independent thinking and positive change is making medical advancement faster and more effective.

The traditional route from innovative ideation to hitting the market is littered with bottlenecks and bureaucracy. However, Hanadi Jabado, managing partner at innovation investment fund Sana Capital, is extolling the virtues of TechBio’s cost-and-time-cutting benefits.

Here, she talks about how independent thinking and positive change is making medical advancement faster and more effective.

Tech Bio: Why data-driven technologies are the way forward

February 16, 2023

As a seasoned Tech Bio investor, Hanadi Jabado understands more than most the importance and implications of using data to transform drug discovery and positively change patient outcomes. Here, she talks to Campden FB about starting the medical and cost-efficient benefits of Tech Bio and the rising importance of ‘data donation’…

As a seasoned Tech Bio investor, Hanadi Jabado understands more than most the importance and implications of using data to transform drug discovery and positively change patient outcomes.

A managing partner at innovation investment fund Sana Capital, Hanadi is a passionate advocate for global information sharing and firmly believes the time is now for private investment in early-stage companies that are set to positively shape the future of healthcare.

Venture capital: Ensuring meaningful impact and return on investment

June 23, 2022

Strategic leader Hanadi Jabado talks about how her impactful investment strategy can do good and do well.

Hanadi Jabado is a passionate advocate for entrepreneurship and innovation. When she relocated to the Cambridge ecosystem, her exposure to the best of tech in Europe allowed her to develop a skill for understanding and explaining the needs of early-stage ventures. With successful investments across diverse sectors, she has since seen many startups go on to great things.

The 3D modelling software set to remap the future of cardiac procedures

March 24, 2022

inHEART is pioneering precise digital maps in a process that could revolutionise cardiac care. Ahead of presenting at the 32nd edition of the MedTech investing (MTi) forum on June 6 and 7, president and chief executive officer Todor Jeliaskov explains the benefits and potential future applications of the platform.

MedTech innovators present as Campden Wealth returns for the 32nd MTi Forum

March 10, 2022

Companies developing robotic assistance for spine surgery, innovative treatment of cataracts, 3D cardiac modelling software, extracorporeal respiratory support systems and therapy for glaucoma surgery scar prophylaxis will exclusively present in-person as Campden Wealth returns to Lausanne, Switzerland, for the 32nd edition of the MedTech Investing Forum on June 6 and 7.

Jaume Sabater on real estate strategy and evolving the family office

December 3, 2021

Family entrepreneur Jaume Sabater is capitalising on the real estate, technological and lifestyle trends accelerated by the pandemic by investing in green residential property developments, revitalising tourist hotels and exploring blockchain opportunities.

The changing face of growth equity in Europe

December 2, 2021

Growth equity is focused on the space between venture capital and traditional private equity. Investments are made often as a large minority stake into companies at earlier stages with proven product/market fit, that are unprofitable or structurally profitable.

Siemon: ‘Why I sustainably invest in PureTerra Ventures and water technology’

October 14, 2021

Siemon, a Dutch entrepreneur, has directed the same passion for sustainable and impact investments with PureTerra Ventures as he had in his lifelong career of IT deals.

Siemon, a Dutch entrepreneur, has directed the same passion for sustainable and impact investments with PureTerra Ventures as he had in his lifelong career of IT deals.

PureTerra’s mission is to enable technologies and entrepreneurs like Siemon to provide dramatic sustainable solutions which match the long-term interest of the global environment.

“I believe in the team, which is heavily invested in the fund themselves and are entrepreneurs,” Siemon said.

Healthcare startups, Esophageal treatment, hybrid air vehicles and water sustainability at next Campden Wealth funds and direct investments webinar

October 13, 2021

Exclusive proposals for early-stage healthcare companies fund, a novel esophagus therapy, a hybrid-electric airship and sustainable investments in water conservation will be heard by qualifying family offices and private investors at the latest virtual Campden Wealth Funds and Direct Investments Event on 21 October.

Each of the four investment opportunities will be introduced in 15-minute slots to all family offices and investors online who will be able to ask questions and discuss the potential returns.

Medtronic leverages reach to commercialise partner products in growth markets

October 6, 2021

With a global presence in more than 150 countries, Medtronic has a deep footprint in the cardiovascular, medical surgical, neuroscience and diabetes MedTech sectors.

With a global presence in more than 150 countries, Medtronic has a deep footprint in the cardiovascular, medical surgical, neuroscience and diabetes MedTech sectors.

We are pleased to report that in our mission to alleviate pain, restore health and extend life, we have had a positive impact on more than 72 million patients during the year despite pandemic-related challenges.